Atlas Trials

Irritation and Sensitization Study of d-Amphetamine Transdermal System

Clinical trial NCT04094025 · COMPLETED

Trial details

NCT number
NCT04094025
Sponsor
Noven Therapeutics
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cumulative Irritation and Sensitization
Start date
2019-12-02
Primary completion
2020-05-16
Enrollment
229

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.